Related Experiment Video
Updated: Oct 18, 2025

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
Pensée Wu1, Ki Park2, Martha Gulati3
1School of Medicine, Keele University Staffordshire, UK.
Insights
Adverse pregnancy outcomes (APOs) signal increased cardiovascular disease (CVD) risk in women. Early atherosclerotic CVD (ASCVD) risk assessment and intervention are crucial for women with APO history.
Area of Science:
- Cardiovascular Medicine
- Obstetrics & Gynecology
- Public Health
Background:
- Adverse pregnancy outcomes (APOs) are linked to increased cardiovascular disease (CVD) risk in women.
- The shared pathogenesis of various APOs suggests a common pathway contributing to later CVD.
- Current CVD risk assessment in women, particularly young women, often underestimates risk.
Purpose of the Study:
- To explore the role of APOs in identifying women at higher risk for future CVD.
- To investigate the potential benefits of atherosclerotic CVD (ASCVD) risk reduction strategies in women with APO history.
- To highlight the need for improved CVD risk assessment and management in women with APOs.
Main Methods:
- This study reviews existing literature and clinical data on the association between APOs and CVD.
- It examines the underlying mechanisms potentially linking APOs to cardiovascular pathology.
- The research analyzes current guidelines for CVD risk assessment in women and identifies gaps.
Main Results:
- APOs serve as an indicator for increased long-term CVD risk.
- The precise relationship between APOs and CVD (causal vs. uncovering predisposition) requires further investigation.
- Aggressive ASCVD risk modification strategies may benefit women with a history of APOs.
Conclusions:
- Women experiencing APOs require vigilant cardiovascular monitoring and risk stratification.
- Further research is essential to refine ASCVD risk assessment tools and interventions for this population.
- Early identification and management of CVD risk factors post-APO are critical for maternal health.
Abstract:
Pregnancy identifies women who may be at a greater risk of cardiovascular disease (CVD), based on the development of adverse pregnancy outcomes (APOs), and may identify women who may benefit from atherosclerotic CVD (ASCVD) risk reduction efforts. APOs are common and although they are separate diagnoses, all these disorders seem to share an underlying pathogenesis. What is not clear is whether the APO itself initiates a pathway that results in CVD or whether the APO uncovers a woman's predisposition to CVD. Regardless, APOs have immediate risks to maternal and foetal health, in addition to longer-term CVD consequences. CVD risk assessment and stratification in women remains complex and, historically, has underestimated risk, especially in young women. Further research is needed into the role of ASCVD risk assessment and the effect of aggressive ASCVD risk modification on CVD outcomes in women with a history of APOs.
Related Concept Videos
Mitral Valve Prolapse III: Nursing Management
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Coronary Artery Disease IV: Preventive Measures
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

